Your browser doesn't support javascript.
loading
Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review.
Gómez-Garre, Pilar; Jesús, Silvia; Periñán, María Teresa; Adarmes, Astrid; Alonso-Canovas, Araceli; Blanco-Ollero, Alberto; Buiza-Rueda, Dolores; Carrillo, Fátima; Catalán-Alonso, María José; Del Val, Javier; Escamilla-Sevilla, Francisco; Espinosa-Rosso, Raúl; Fernández-Moreno, María Carmen; García-Moreno, José Manuel; García-Ruiz, Pedro José; Giacometti-Silveira, Sandra; Gutiérrez-García, Javier; López-Valdés, Eva; Macías-García, Daniel; Martínez-Castrillo, Juan Carlos; Martínez-Torres, Irene; Medialdea-Natera, María Pilar; Mínguez-Castellanos, Adolfo; Moya, Miguel Ángel; Ochoa-Sepulveda, Juan José; Ojea, Tomás; Rodríguez, Nuria; Sillero-Sánchez, Miriam; Tejera-Parrado, Cristina; Mir, Pablo.
  • Gómez-Garre P; Movement Disorders Unit, Clinical Neurology and Neurophysiology Department, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
  • Jesús S; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED, Madrid, Spain.
  • Periñán MT; Movement Disorders Unit, Clinical Neurology and Neurophysiology Department, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
  • Adarmes A; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED, Madrid, Spain.
  • Alonso-Canovas A; Movement Disorders Unit, Clinical Neurology and Neurophysiology Department, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
  • Blanco-Ollero A; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED, Madrid, Spain.
  • Buiza-Rueda D; Movement Disorders Unit, Clinical Neurology and Neurophysiology Department, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
  • Carrillo F; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED, Madrid, Spain.
  • Catalán-Alonso MJ; Movement Disorders Unit, Neurology Department, Ramón y Cajal Hospital, IRYCIS, Madrid, Spain.
  • Del Val J; Neurology Department, Juan Ramón Jiménez Hospital, Huelva, Spain.
  • Escamilla-Sevilla F; Movement Disorders Unit, Clinical Neurology and Neurophysiology Department, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
  • Espinosa-Rosso R; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED, Madrid, Spain.
  • Fernández-Moreno MC; Movement Disorders Unit, Clinical Neurology and Neurophysiology Department, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
  • García-Moreno JM; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED, Madrid, Spain.
  • García-Ruiz PJ; Movement Disorders Unit, Neurology Department, La Fe Hospital, Valencia, Spain.
  • Giacometti-Silveira S; Movement Disorders Unit, Neurology Department, San Carlos Clinical Hospital, Madrid, Spain.
  • Gutiérrez-García J; Movement Disorders Unit, Neurology Department, Virgen de las Nieves University Hospital, Granada, Spain.
  • López-Valdés E; Neurology Department, Puerta del Mar University Hospital, Cádiz, Spain.
  • Macías-García D; Neurology Department, Virgen de Valme Hospital, Seville, Spain.
  • Martínez-Castrillo JC; Movement Disorders Unit, Neurology Department, Jiménez Díaz Foundation, Madrid, Spain.
  • Martínez-Torres I; Movement Disorders Unit, Neurology Department, San Carlos Clinical Hospital, Madrid, Spain.
  • Medialdea-Natera MP; Neurology Department, Virgen Macarena University Hospital, Seville, Spain.
  • Mínguez-Castellanos A; Neurology Department, Carlos Haya Hospital, Málaga, Spain.
  • Moya MÁ; Movement Disorders Unit, Neurology Department, La Fe Hospital, Valencia, Spain.
  • Ochoa-Sepulveda JJ; Movement Disorders Unit, Clinical Neurology and Neurophysiology Department, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
  • Ojea T; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED, Madrid, Spain.
  • Rodríguez N; Movement Disorders Unit, Neurology Department, Ramón y Cajal Hospital, IRYCIS, Madrid, Spain.
  • Sillero-Sánchez M; Neurology Department, San Cecilio University Hospital, Granada, Spain.
  • Tejera-Parrado C; Movement Disorders Unit, Neurology Department, Virgen de la Victoria University Hospital, Málaga, Spain.
  • Mir P; Movement Disorders Unit, Neurology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Eur J Neurol ; 28(4): 1188-1197, 2021 04.
Article en En | MEDLINE | ID: mdl-33175450
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Distónicos / Distonía Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Distónicos / Distonía Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article